Drug firm Venus Remedies Ltd said it has received patent grants for its antibiotic drug Sulbactomax from Russian and Ukrainian authorities.
The patent has been granted by Federal Service on Intellectual Property, Patents and Trademarks, Russia and State Enterprise Ukrainian Institute of Industrial Property, Ukraine, Venus Remedies said in a filing to the Bombay Stock Exchange (BSE).
With this patent grant the company can now enter the $780 million anti-biotic market in Russia and also strengthen its presence in Ukrainian market, it added.
Sulbactomax is used in treating bacterial infections, including respiratory tract and urinary tract infections.
The world antibiotic market is presently estimated to be around $37.14 billion and is expected to be $55.18 billion by 2013, it said.
On Monday, Venus ended 1.55% up at Rs265.40 on the BSE, while the benchmark Sensex gained 0.22% to 20,028 points.
Hindustan Dorr-Oliver Ltd said it won an order worth Rs135 crore for their mineral and water division.
The company said in a statement it won an order worth Rs63 crore from heavy water Board, government of India towards designing, engineering and manufacturing at the Department of Atomic Energy at their Kalpakam facility and the completion period of the project is 16 months.
Another order worth Rs36.5 crore is for effluent treatment plant (ETP) plant for the first ever Aromatic complex from ONGC-Mangalore Petrochemicals Ltd. The order is for complete effluent treatment plant of capacity 200 cum/hr for the Atomic SEZ.
The project is expected to be executed in 20 months.
On Monday, Hindustan Dorr-Oliver ended 1.19% up at Rs114.45 on the Bombay Stock Exchange, while the benchmark Sensex gained 0.22% to 20,028 points.
Reliance Infrastructure Ltd has won a consultancy project under R-APDRP Programme of Union Ministry of Power. This time the company has been awarded the project of SCADA (Supervisory Control and Data Acquisition)-DMS (Distribution Management System) consultancy for Patna city in Bihar.
The project has been awarded to RInfra in line with its highest scoring in the technical bid; which had a 70% weightage in the entire bidding process; rest 30% weightage was for the financial bid. RInfra was weighed at 57.5% as against its nearer competitor bidder who scored only 17%. RInfra also supersede in financial bidding by offering low cost of Rs54 lakh as against the cost offered at very high level by the nearer competitor, i.e., Rs1.97 crore.
On Monday, RInfra declined 2.11% to Rs797.60 on the Bombay Stock Exchange, while the benchmark Sensex gained 0.22% to 20,028 points.